$10.92
-0.22-1.97%
At close: -
$10.90
-0.02-0.18%
After Hours: Jan 24, 5:50 PM EDT
Pliant Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pliant Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-0.95 | $-0.98 | 3.06 % |
Q2 | 2024-08-07 | $-0.92 | $-0.85 | -8.24 % |
Q1 | 2024-05-06 | $-0.78 | $-0.77 | -1.30 % |
Q4 | 2024-02-28 | $-0.69 | $-0.81 | 14.8 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $0 | $530.00K | -100.0 % |
Q1 | 2024-05-06 | $0 | $460.00K | -100.0 % |
Q4 | 2024-02-28 | $0 | $500.00K | -100.0 % |
Q3 | 2023-11-09 | $0 | $700.00K | -100.0 % |
Pliant Therapeutics (PLRX) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.95, which beat the estimate of $-0.98.
The Actual Revenue was $0K, which missed the estimate of $530K.
Browse earnings estimates, EPS, and revenue on all stocks.